Caris Life Sciences, Inc. Common Stock Cash Flow-to-Debt Ratio
Caris Life Sciences, Inc. Common Stock cash flow-to-debt ratio. Caris Life Sciences, Inc. Common Stock (CAI) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2026, meaning its operating cash flow of $61.35 Million could theoretically repay 0% of its total liabilities ($637.89 Million) in one year. Check CAI cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Caris Life Sciences, Inc. Common Stock (2005–2025)
Cash flow-to-debt ratio of Caris Life Sciences, Inc. Common Stock from 2005 to 2025. Historical debt coverage capacity for Caris Life Sciences, Inc. Common Stock across 20 annual periods. Check CAI capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Caris Life Sciences, Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2005–2025)
Caris Life Sciences, Inc. Common Stock cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for Caris Life Sciences, Inc. Common Stock. For the full cash flow conversion analysis, see Caris Life Sciences, Inc. Common Stock cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | $83.16 Million | $548.36 Million | ▲ +275.8% |
| 2024 | -0.09x | $-245.20 Million | $2.84 Billion | ▲ +20.1% |
| 2023 | -0.11x | $-276.10 Million | $2.56 Billion | ▲ +8.6% |
| 2022 | -0.12x | $-285.71 Million | $2.42 Billion | ▼ -181.4% |
| 2020 | 0.15x | $277.02 Million | $1.91 Billion | ▲ +26.1% |
| 2019 | 0.12x | $254.00 Million | $2.21 Billion | ▲ +47.9% |
| 2018 | 0.08x | $179.77 Million | $2.31 Billion | ▼ -6.5% |
| 2017 | 0.08x | $155.19 Million | $1.87 Billion | ▲ +2.8% |
| 2016 | 0.08x | $129.26 Million | $1.60 Billion | ▼ -16.3% |
| 2015 | 0.10x | $147.37 Million | $1.53 Billion | ▼ -6.4% |
| 2014 | 0.10x | $139.69 Million | $1.35 Billion | ▲ +4.8% |
| 2013 | 0.10x | $124.19 Million | $1.26 Billion | ▼ -4.0% |
| 2012 | 0.10x | $106.83 Million | $1.04 Billion | ▲ +0.3% |
| 2011 | 0.10x | $72.11 Million | $704.63 Million | ▲ +0.3% |
| 2010 | 0.10x | $42.42 Million | $415.78 Million | ▼ -18.8% |
| 2009 | 0.13x | $30.80 Million | $244.99 Million | ▲ +36.9% |
| 2008 | 0.09x | $27.44 Million | $298.84 Million | ▲ +7968.2% |
| 2007 | 0.00x | $-266.00K | $227.95 Million | ▼ -103.6% |
| 2006 | 0.03x | $8.38 Million | $255.25 Million | ▼ -83.5% |
| 2005 | 0.20x | $29.41 Million | $147.67 Million | — |